|
May 10
|
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
|
|
May 2
|
Q1 2024 Emergent BioSolutions Inc Earnings Call
|
|
May 2
|
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
|
|
May 2
|
PRESS DIGEST- Wall Street Journal - May 2
|
|
May 2
|
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
|
|
May 1
|
Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
|
|
May 1
|
Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
|
|
May 1
|
Emergent BioSolutions Reports First Quarter 2024 Financial Results
|
|
May 1
|
Emergent BioSolutions to lay off about 300 employees
|
|
May 1
|
UPDATE 2-Emergent BioSolutions to lay off about 300 employees
|
|
May 1
|
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
|
|
May 1
|
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
|
|
Apr 30
|
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
|
|
Apr 22
|
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
|
|
Apr 17
|
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses
|
|
Apr 1
|
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
|
|
Mar 28
|
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
|
|
Mar 25
|
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
|
|
Mar 7
|
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
|